Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Biochemical Society Transactions|October 25, 2007
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implicationsC Alarcón de la Lastra, I VillegasPlanta Medica|December 1, 1993
Gastroprotection and prostaglandin E2 generation in rats by flavonoids of Dittrichia viscosaC Alarcón de la Lastra, A López, V MotilvaCurrent Pharmaceutical Design|July 27, 2001
New issues about melatonin and its effects on the digestive systemV Motilva, J Cabeza, C Alarcón de la LastraThe Journal of Pharmacy and Pharmacology|February 1, 1994
Ulcer-protecting effects of naringenin on gastric lesions induced by ethanol in rat: role of endogenous prostaglandinsV Motilva, C Alarcón de la Lastra, M J MartínCurrent Pharmaceutical Design|April 14, 2007
Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implicationsC Alarcón de la Lastra, I Villegas, S Sánchez-FidalgoPharmacology|January 1, 1994
Antiulcer and gastroprotective effects of quercetin: a gross and histologic studyC Alarcón de la Lastra, M J Martín, V MotilvaGeneral Pharmacology|October 1, 1994
Antisecretory and gastroprotective effects of aescine in ratsE Marhuenda, C Alarcón de la Lastra, M J MartínInflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 11, 2005
The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in miceA R Martín, I Villegas, C Alarcón de la LastraCurrent Medicinal Chemistry|July 10, 2013
An up-date of olive oil phenols in inflammation and cancer: molecular mechanisms and clinical implicationsA Cárdeno, M Sánchez-Hidalgo, C Alarcón-de-la-LastraCurrent Pharmaceutical Design|December 8, 2004
New pharmacological perspectives and therapeutic potential of PPAR-gamma agonistsC Alarcón de la Lastra, S Sánchez-Fidalgo, I Villegas, et al.Pageof 5